Healthy Skepticism Library Topics: Samples

Samples

This page lists 60 references in the Main Healthy Skepticism Library relevant to Samples.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.

HSL6960
Symm B, Averitt M, Forjuoh SN, Preece C.
Effects of Using Free Sample Medications on the Prescribing Practices of Family Physicians
Journal of the American Board of Family Medicine 2006 Oct 17
http://www.medscape.com/viewarticle/545405_print

HSL6882
Flewell MN.
Pharmaceutical sales reps: value beyond samples.
Adv Nurse Pract 2006 Jul 01;14(7):18

HSL5814
Adair R.
Hidden costs of free samples
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):367-371
http://www.ama-assn.org/ama/pub/category/16251.html

HSL4370
Hall KB, Tett SE, Nissen LM.
Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians.
Med Care 2006 Apr 1;44(4):383-387
Link to source with long URL

HSL5980
Klein CA.
Dispensing pharmaceutical samples: a few reminders.
Nurse Pract 2006 Apr 01;31(4):15
Link to source with long URL

HSL5599
Lohiya S.
A simple stratification & storage system for samples and supplies.
J Natl Med Assoc 2006 Mar;98(3):405-7

HSL6735
Morgan MA, Dana J, Loewenstein G, Zinberg S, .
Interactions of doctors with the pharmaceutical industry
J Med Ethics 2006;32:559-563
http://jme.bmjjournals.com/cgi/content/full/32/10/559

HSL5262
Komesaroff PA.
Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.
J Paediatr Child Health 2005 Nov;41(11):558-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1754.2005.00719.x

HSL2429
Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug;118(8):881-4
http://www.amjmed.com/article/PIIS000293430500197X/fulltext

HSL6577
Stewart D.
Beyond the sales pitch and samples.
Minn Med 2005 Mar 01;88(3):36-7

HSL5317
Brody H.
The company we keep: why physicians should refuse to see pharmaceutical representatives.
Ann Fam Med 2005 Jan-Feb;3(1):82-5
http://www.annfammed.org/cgi/content/full/3/1/82

HSL5282
Castresana L, Mejia R, Aznar M.
[The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Medicina (B Aires) 2005;65(3):247-51

HSL1926
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG.
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.
Med Care 2004 Dec;42(12):1176-85
Link to source with long URL

HSL1977
MacKinnon NJ.
Use of drug samples as a threat to seamless health care.
Am J Health Syst Pharm 2004 Jul 15;61(14):1497-500
http://www.ajhp.org/cgi/reprint/61/14/1497.pdf

HSL2817
Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria.
[Ethics in drug industry relations.
Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15;34(1):6-12
Link to source with long URL

HSL1368
Sorensen TD, Song J, Westberg SM.
The limitation of good intentions: prescribing medications for the uninsured.
J Health Care Poor Underserved 2004 May;15(2):152-60

HSL1372
Using drug samples can hinder quality
Healthcare Benchmarks Qual Improv 2004 Mar;11(3):34-5

HSL2798
Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA.
Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting.
Am J Health Syst Pharm 2004 Feb 1;61(3):267-72
http://www.ajhp.org/cgi/reprint/61/3/267

HSL2152
Keim SM, Mays MZ, Grant D.
Interactions between emergency medicine programs and the pharmaceutical industry.
Acad Emerg Med 2004 Jan;11(1):19-26
http://www.aemj.org/cgi/content/full/11/1/19

HSL2712
Mizik M, Jacobsen R
Are Physicians Easy Marks?: Quantifying the effects of Detailing and Sampling on New Prescriptions.
Unpublished 2003 Oct
Nil

HSL1434
Groves KE, Sketris I, Tett SE.
Prescription drug samples--does this marketing strategy counteract policies for quality use of medicines?
J Clin Pharm Ther 2003 Aug;28(4):259-71
Link to source with long URL

HSL2911
Drug companies offer DM programs for MS patients.
Dis Manag Advis. 2002 Nov 01;8(11):165-8, 161
Link to source with long URL

HSL2899
Boltri JM, Gordon ER, Vogel RL.
Effect of antihypertensive samples on physician prescribing patterns.
Fam Med 2002 Nov-Dec;34(10):729-31
Link to source with long URL

HSL2885
Coolidge MP.
Drug samples: friend or foe?
J Drugs Dermatol 2002 Jul;1(1):49-52
Link to source with long URL

HSL2896
Brody H.
A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs
Health Affairs (Millwood). 2002 Mar-Apr;21(2):232-234
http://www.healthaffairs.org/freecontent/s28.htm

HSL5341
Thawani V.
Drug samples are meant for advertising.
Issues Med Ethics 2001 Jul-Sep;9(3):91

HSL121
Stout E.
Doctoring sales
Sales & Marketing Management 2001 May:52-60
Nil

HSL2764
Goodman B.
Do drug company promotions influence physician behavior?
West J Med 2001 Apr;174(4):232-3

HSL2752
Sibbald , B .
Doctors asked to take pledge to shun drug company freebies
CMAJ 2001 Feb 01;164(4):531

HSL2741
Lal A.
Pharmaceutical drug promotion: how it is being practiced in India?
J Assoc Physicians India 2001 Feb;49:266-73

HSL130
Gönül FF, Carter F, Petrova E, Srinivasan K.
Promotion of prescription drugs and its impact on physicians' choice behavior
Journal of Marketing 2001;65:79-90
Nil

HSL360
Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF.
The value of pharmaceutical representative visits and medication samples in community-based family practices.
J Fam Pract 2000 Sep;49(9):811-6
Nil

HSL2998
Sams WM, Freedberg IM.
The dermatology-industry interface: defining the boundaries.
J Am Acad Dermatol 2000 Sep;43(3):550-4
Link to source with long URL

HSL354
Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS.
A physician survey of the effect of drug sample availability on physicians' behavior.
J Gen Intern Med 2000 Jul;15(7):478-83
Nil

HSL708
Lewin-Fetter V.
Pharmaceutical representatives.
Lancet 1997 Dec 13;350(9093):1784

HSL2185
Shaughnessy AF, Bucci KK.
Drug samples and family practice residents.
Ann Pharmacother 1997 Nov;31(11):1296-300

HSL559
Westfall JM, McCabe J, Nicholas RA.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Jul 9;278(2):141-3
Link to source with long URL

HSL681
Sanders HD.
Physician-detailer interaction—I.
Can J Clin Pharmacol 1997;4(1):9
Nil

HSL756
Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, Etchells E, Davidson W.
National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
Ann R Coll Physicians Surg Can 1996 Dec;29(8):474-8

HSL816
Tong KL, Lien CY.
Do pharmaceutical representatives misuse their drug samples?
Can Fam Physician 1995 Aug;41:1363-6

HSL1884
Sigmon JL, Anastasio GD.
Drug sample closet.
J Fam Pract 1992 Mar;34(3):262-3

HSL4631
Saade C, Huff-rousselle M.
Pakistan: should ORS be marketed like other drugs?
Dialogue on Diarrhoea 1990 Sep(42):6

HSL4528
Erola J.
A sample response
Canadian Medical Association Journal 1990;143:129

HSL4572
Robinson WK.
A sample argument
Canadian Medical Association Journal 1990;143:611

HSL4598
Timpany J.
A sample argument
Canadian Medical Association Journal 1990;143:129

HSL4410
Fogel ML.
Survey of pharmaceutical promotion in a family medicine training program
Canadian Family Physician 1989;35:1603-1605

HSL4412
Franklin K.
The pharmaceutical tango
New Physician 1989;38(5):24-28

HSL4437
Martin JH.
The ethics of physician-pharmaceutical company relationships
Canadian Medical Association Journal 1989;140:10

HSL4071
Storrs FJ.
Drug samples? A conflict of interest
Arch Dermatol. 1988 Aug 01;124(8):1283-5

HSL4088
Healthcare communications and pharmaceutical promotion
Health Horizons 1988 May(4):16-17

HSL4011
Krass M.
New code for drug makers tightens rules on drug samples, research.
CMAJ 1988 Apr 1;138(7):646

HSL4077
Weary PE.
Free drug samples: Use and abuse.
Arch Dermatol 1988 Jan 12;4(1):125-7

HSL3903
Lexchin J.
Pharmaceutical promotion in Canada: convince them or confuse them.
Int J Health Serv 1987;17(1):77-89

HSL3757
Congressional panel wants to ban drug samples
Canadian Medical Association Journal 1986;134:1302

HSL3705
The battle over physicians’ samples
Lancet 1985;2:1001

HSL3641
Lexchin J.
The real pushers: a critical analysis of the Canadian drug industry
1984

HSL3517
Meadows R.
Communicating new drug information—the medium is the message
Drug Information Journal 1981;15:11-15

HSL3395
Kalb CC.
Psychological motivations in physician prescribing habits.
Med Mark Media 1978 Oct;13(10):43-5,

HSL3397
Lall S, Bibile S.
The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976.
Int J Health Serv 1978;8(2):299-328

HSL3246
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts VII-Viii
Drug Intelligence and Clinical Pharmacy 1974;8:81-91

		Healthy Skepticism Countering misleading drug promotion Home \| About us \| Site info \| Contact us \| Links \| Other What's new \| AdWatch \| HS Int News \| Library \| Fora
Home - www.healthyskepticism.org > library > topics: Samples : Updated 23 August, 2005
For you Free Updates Can we help you? Help the cause Join in Subscribe to Healthy Skepticism Updates Feedback If you like our work please tell others. If not, please tell us.		Samples This page lists 60 references in the Main Healthy Skepticism Library relevant to Samples. Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text. HSL6960 Symm B, Averitt M, Forjuoh SN, Preece C. Effects of Using Free Sample Medications on the Prescribing Practices of Family Physicians Journal of the American Board of Family Medicine 2006 Oct 17 http://www.medscape.com/viewarticle/545405_print HSL6882 Flewell MN. Pharmaceutical sales reps: value beyond samples. Adv Nurse Pract 2006 Jul 01;14(7):18 HSL5814 Adair R. Hidden costs of free samples Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):367-371 http://www.ama-assn.org/ama/pub/category/16251.html HSL4370 Hall KB, Tett SE, Nissen LM. Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians. Med Care 2006 Apr 1;44(4):383-387 Link to source with long URL HSL5980 Klein CA. Dispensing pharmaceutical samples: a few reminders. Nurse Pract 2006 Apr 01;31(4):15 Link to source with long URL HSL5599 Lohiya S. A simple stratification & storage system for samples and supplies. J Natl Med Assoc 2006 Mar;98(3):405-7 HSL6735 Morgan MA, Dana J, Loewenstein G, Zinberg S, . Interactions of doctors with the pharmaceutical industry J Med Ethics 2006;32:559-563 http://jme.bmjjournals.com/cgi/content/full/32/10/559 HSL5262 Komesaroff PA. Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment. J Paediatr Child Health 2005 Nov;41(11):558-60 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1754.2005.00719.x HSL2429 Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 2005 Aug;118(8):881-4 http://www.amjmed.com/article/PIIS000293430500197X/fulltext HSL6577 Stewart D. Beyond the sales pitch and samples. Minn Med 2005 Mar 01;88(3):36-7 HSL5317 Brody H. The company we keep: why physicians should refuse to see pharmaceutical representatives. Ann Fam Med 2005 Jan-Feb;3(1):82-5 http://www.annfammed.org/cgi/content/full/3/1/82 HSL5282 Castresana L, Mejia R, Aznar M. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry]. Medicina (B Aires) 2005;65(3):247-51 HSL1926 Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care 2004 Dec;42(12):1176-85 Link to source with long URL HSL1977 MacKinnon NJ. Use of drug samples as a threat to seamless health care. Am J Health Syst Pharm 2004 Jul 15;61(14):1497-500 http://www.ajhp.org/cgi/reprint/61/14/1497.pdf HSL2817 Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria. [Ethics in drug industry relations. Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15;34(1):6-12 Link to source with long URL HSL1368 Sorensen TD, Song J, Westberg SM. The limitation of good intentions: prescribing medications for the uninsured. J Health Care Poor Underserved 2004 May;15(2):152-60 HSL1372 Using drug samples can hinder quality Healthcare Benchmarks Qual Improv 2004 Mar;11(3):34-5 HSL2798 Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA. Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting. Am J Health Syst Pharm 2004 Feb 1;61(3):267-72 http://www.ajhp.org/cgi/reprint/61/3/267 HSL2152 Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med 2004 Jan;11(1):19-26 http://www.aemj.org/cgi/content/full/11/1/19 HSL2712 Mizik M, Jacobsen R Are Physicians Easy Marks?: Quantifying the effects of Detailing and Sampling on New Prescriptions. Unpublished 2003 Oct Nil HSL1434 Groves KE, Sketris I, Tett SE. Prescription drug samples--does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther 2003 Aug;28(4):259-71 Link to source with long URL HSL2911 Drug companies offer DM programs for MS patients. Dis Manag Advis. 2002 Nov 01;8(11):165-8, 161 Link to source with long URL HSL2899 Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med 2002 Nov-Dec;34(10):729-31 Link to source with long URL HSL2885 Coolidge MP. Drug samples: friend or foe? J Drugs Dermatol 2002 Jul;1(1):49-52 Link to source with long URL HSL2896 Brody H. A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs Health Affairs (Millwood). 2002 Mar-Apr;21(2):232-234 http://www.healthaffairs.org/freecontent/s28.htm HSL5341 Thawani V. Drug samples are meant for advertising. Issues Med Ethics 2001 Jul-Sep;9(3):91 HSL121 Stout E. Doctoring sales Sales & Marketing Management 2001 May:52-60 Nil HSL2764 Goodman B. Do drug company promotions influence physician behavior? West J Med 2001 Apr;174(4):232-3 HSL2752 Sibbald , B . Doctors asked to take pledge to shun drug company freebies CMAJ 2001 Feb 01;164(4):531 HSL2741 Lal A. Pharmaceutical drug promotion: how it is being practiced in India? J Assoc Physicians India 2001 Feb;49:266-73 HSL130 Gönül FF, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior Journal of Marketing 2001;65:79-90 Nil HSL360 Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract 2000 Sep;49(9):811-6 Nil HSL2998 Sams WM, Freedberg IM. The dermatology-industry interface: defining the boundaries. J Am Acad Dermatol 2000 Sep;43(3):550-4 Link to source with long URL HSL354 Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 2000 Jul;15(7):478-83 Nil HSL708 Lewin-Fetter V. Pharmaceutical representatives. Lancet 1997 Dec 13;350(9093):1784 HSL2185 Shaughnessy AF, Bucci KK. Drug samples and family practice residents. Ann Pharmacother 1997 Nov;31(11):1296-300 HSL559 Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA 1997 Jul 9;278(2):141-3 Link to source with long URL HSL681 Sanders HD. Physician-detailer interaction—I. Can J Clin Pharmacol 1997;4(1):9 Nil HSL756 Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, Etchells E, Davidson W. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives. Ann R Coll Physicians Surg Can 1996 Dec;29(8):474-8 HSL816 Tong KL, Lien CY. Do pharmaceutical representatives misuse their drug samples? Can Fam Physician 1995 Aug;41:1363-6 HSL1884 Sigmon JL, Anastasio GD. Drug sample closet. J Fam Pract 1992 Mar;34(3):262-3 HSL4631 Saade C, Huff-rousselle M. Pakistan: should ORS be marketed like other drugs? Dialogue on Diarrhoea 1990 Sep(42):6 HSL4528 Erola J. A sample response Canadian Medical Association Journal 1990;143:129 HSL4572 Robinson WK. A sample argument Canadian Medical Association Journal 1990;143:611 HSL4598 Timpany J. A sample argument Canadian Medical Association Journal 1990;143:129 HSL4410 Fogel ML. Survey of pharmaceutical promotion in a family medicine training program Canadian Family Physician 1989;35:1603-1605 HSL4412 Franklin K. The pharmaceutical tango New Physician 1989;38(5):24-28 HSL4437 Martin JH. The ethics of physician-pharmaceutical company relationships Canadian Medical Association Journal 1989;140:10 HSL4071 Storrs FJ. Drug samples? A conflict of interest Arch Dermatol. 1988 Aug 01;124(8):1283-5 HSL4088 Healthcare communications and pharmaceutical promotion Health Horizons 1988 May(4):16-17 HSL4011 Krass M. New code for drug makers tightens rules on drug samples, research. CMAJ 1988 Apr 1;138(7):646 HSL4077 Weary PE. Free drug samples: Use and abuse. Arch Dermatol 1988 Jan 12;4(1):125-7 HSL3903 Lexchin J. Pharmaceutical promotion in Canada: convince them or confuse them. Int J Health Serv 1987;17(1):77-89 HSL3757 Congressional panel wants to ban drug samples Canadian Medical Association Journal 1986;134:1302 HSL3705 The battle over physicians’ samples Lancet 1985;2:1001 HSL3641 Lexchin J. The real pushers: a critical analysis of the Canadian drug industry 1984 HSL3517 Meadows R. Communicating new drug information—the medium is the message Drug Information Journal 1981;15:11-15 HSL3395 Kalb CC. Psychological motivations in physician prescribing habits. Med Mark Media 1978 Oct;13(10):43-5, HSL3397 Lall S, Bibile S. The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976. Int J Health Serv 1978;8(2):299-328 HSL3246 Miller RR. Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts VII-Viii Drug Intelligence and Clinical Pharmacy 1974;8:81-91
1130 visits to this page since 1 January 2007		Home \| Add to Favourites \| Site Map \| Credits \| Privacy Policy \| Update Policy \| Feedback Policy

Countering misleading drug promotion

Samples